JESSICA AWBERY: Open Payments
NPI 1740052174 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 21 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $84 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $143 |
| Indivior Inc. | 3 | $111 |
| Otsuka America Pharmaceutical, Inc. | 3 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Gilead Sciences, Inc. | 3 | $50 |
| Stryker Corporation | 1 | $24 |
Products named: VRAYLAR, SUBLOCADE, CAPLYTA, REXULTI, LEQVIO, ABILIFY MAINTENA, FLOWTRIEVER CATHETER, S.
Industry payments across KY — which companies pay providers there.
